The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?. (1st February 2018)

Record Type:: Journal Article
Title:: The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?. (1st February 2018)
Main Title:: The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?
Authors:: Geller, S.
Myskowski, P.L.
Kim, Y.H.
Moskowitz, A.
Horwitz, S.
Abstract:
Is Part Of:: British journal of dermatology. Volume 178:Number 2(2018)
Journal:: British journal of dermatology
Issue:: Volume 178:Number 2(2018)
Issue Display:: Volume 178, Issue 2 (2018)
Year:: 2018
Volume:: 178
Issue:: 2
Issue Sort Value:: 2018-0178-0002-0000
Page Start:: 571
Page End:: 571
Publication Date:: 2018-02-01
Subjects:: Dermatology -- Periodicals
Skin -- Diseases -- Periodicals
616.5
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2133 ↗
https://academic.oup.com/bjd ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjd.16052 ↗
Languages:: English
ISSNs:: 0007-0963
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2307.400000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24815.xml